Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Am Geriatr Soc. 2020 Oct 9;69(1):173–179. doi: 10.1111/jgs.16854

Table 2.

Scores on Well-Being Measures over Time by Treatment Groupa

Concern about fallingb
Anxietyc
Depressionc
Physical functiond
Disabilityd
Time point Treatment group N (missing) Mean (SE) N (missing) Mean (SE) N (missing) Mean (SE) N (missing) Mean (SE) N (missing) Mean (SE)
Baseline intervention 372 (12) 15.4 (.28) 371 (13) 12.5 (.26) 372 (12) 12.1 (.26) 380 (4) 60.2 (.46) 380 (4) 57.3 (.53)
Control 351 (8) 15.7 (.29) 350 (9) 12.4 (.27) 350 (9) 12.0 (.26) 358 (1) 58.9 (.47) 358 (1) 56.2 (.51)
12 months Intervention 320 (1) 15.2 (.30) 319 (2) 11.6 (.25) 319 (2) 11.5 (.26) 313 (23) 59.8 (.54) 313 (23) 56.4 (.64)
Control 300 (4) 15.3 (.35) 293 (11) 12.3 (.32) 295 (9) 12.2 (.32) 284 (30) 58.9 (.57) 283 (31) 55.8 (.66)
24 months Intervention 286 (27) 15.8 (.37) 282 (31) 11.6 (.27) 282 (31) 11.6 (.25) 290 (23) 59.1 (.61) 290 (23) 56.7 (.76)
Control 262 (17) 15.5 (.36) 260 (19) 12.2 (.31) 260 (19) 12.4 (.34) 257 (22) 58.0 (.53) 256 (23) 55.8 (.63)

Abbreviation: SE, standard error.

a

At baseline, the intervention group included 384 participants; the control group included 359 participants. Information about losses to follow-up at 12 and 24 months is provided in Supplementary Table S2. Missing values represent participants who completed at least part of the assessment.

b

Assessed with a modified version of the Fall Efficacy Scale, with scores ranging from 10 (low) to 40 (high).

c

Assessed with 8-item PROMIS scales, with scores ranging from 8 (low) to 40 (high).

d

Assessed with the computer-adapted test version of the Late-Life Function and Disability Instrument, with scores ranging from 0 (worst) to 100 (best).